Contraline
Drug DiscoveryWebsite
Developer of a male contraceptive product intended to provide non-surgical and reversible birth control procedures. The company's technology implants a non-hormonal, non-surgical, and reversible polym...
Valuation
$60M
Market implied
Share Price
N/A
Total Raised
$41.7M
Last Round
Later Stage VC
Apr 2022
Latest Funding Round
Later Stage VC
Apr 5, 2022
$7.2M
raised
Investors
+50 other investors